ALDX
Price
$3.97
Change
+$0.10 (+2.58%)
Updated
Apr 17, 6:59 PM EST
14 days until earnings call
VKTX
Price
$66.47
Change
-$1.48 (-2.18%)
Updated
Apr 17, 6:59 PM EST
6 days until earnings call
Ad is loading...

Analysis and predictions ALDX vs VKTX

Header iconALDX vs VKTX Comparison
Open Charts ALDX vs VKTXBanner chart's image
Aldeyra Therapeutics
Price$3.97
Change+$0.10 (+2.58%)
Volume$378.04K
CapitalizationN/A
Viking Therapeutics
Price$66.47
Change-$1.48 (-2.18%)
Volume$1.1M
CapitalizationN/A
View a ticker or compare two or three
ALDX vs VKTX Comparison Chart

Loading...

ALDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VKTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALDX vs. VKTX commentary
Apr 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and VKTX is a StrongSell.

COMPARISON
Comparison
Apr 18, 2024
Stock price -- (ALDX: $3.97 vs. VKTX: $66.47)
Brand notoriety: ALDX and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 99% vs. VKTX: 26%
Market capitalization -- ALDX: $234.41M vs. VKTX: $7.33B
ALDX [@Biotechnology] is valued at $234.41M. VKTX’s [@Biotechnology] market capitalization is $7.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $551.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALDX and VKTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 2 bullish TA indicator(s).

  • ALDX’s TA Score: 5 bullish, 5 bearish.
  • VKTX’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, ALDX is a better buy in the short-term than VKTX.

Price Growth

ALDX (@Biotechnology) experienced а -6.59% price change this week, while VKTX (@Biotechnology) price change was -7.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was +1228.23%.

Reported Earning Dates

ALDX is expected to report earnings on Aug 02, 2024.

VKTX is expected to report earnings on Jul 24, 2024.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALDX with price predictions.
OPEN
A.I.dvisor published
a Summary for VKTX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VKTX($7.33B) has a higher market cap than ALDX($234M). VKTX YTD gains are higher at: 257.174 vs. ALDX (13.105).
ALDXVKTXALDX / VKTX
Capitalization234M7.33B3%
EBITDAN/AN/A-
Gain YTD13.105257.1745%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
ALDX vs VKTX: Fundamental Ratings
ALDX
VKTX
OUTLOOK RATING
1..100
1978
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
10013
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
3734
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
533

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for VKTX (78). This means that ALDX’s stock grew somewhat faster than VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (13) in the Biotechnology industry is significantly better than the same rating for ALDX (100). This means that VKTX’s stock grew significantly faster than ALDX’s over the last 12 months.

ALDX's SMR Rating (95) in the Biotechnology industry is in the same range as VKTX (96). This means that ALDX’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Price Growth Rating (34) in the Biotechnology industry is in the same range as ALDX (37). This means that VKTX’s stock grew similarly to ALDX’s over the last 12 months.

VKTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ALDX (100). This means that VKTX’s stock grew similarly to ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXVKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 23 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
ALDXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VKTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMGIX15.900.18
+1.12%
Frontier MFG Core Infrastructure Instl
SSAIX10.79N/A
N/A
State Street International Stock Sel N
WCMWX13.02-0.03
-0.23%
WCM Focused Emerging Mkts Ex Chn Inst
TSMOX13.94-0.12
-0.85%
TIAA-CREF Quant Sm/Md-Cp Eq Retirement
HGOSX52.76-0.61
-1.14%
Hartford Growth Opportunities R4

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with OMER. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+2.58%
OMER - ALDX
48%
Loosely correlated
-2.62%
CANF - ALDX
46%
Loosely correlated
-5.77%
ORMP - ALDX
45%
Loosely correlated
-2.92%
CDMO - ALDX
35%
Loosely correlated
-7.45%
ARRY - ALDX
35%
Loosely correlated
-2.02%
More